Cuba's Covid-19 vaccine on international media's agenda

especiales

In this article:

Cuba

By:

Fecha de publicación:

17 February 2021

Imagen principal:

Havana, Feb 17 (Prensa Latina) International press media are currently reviewing Cuba's work to obtain its own Covid-19 vaccine, and highlighting the country's scientific work that is currently developing four candidates.

The Business Insider website, one of the main U.S. financial and economic news sites, highlighted the progress of the proposals Soberana 01 and Soberana 02 of the Finlay Institute in the Caribbean island; and Abdala and Mambisa, of the Center for Genetic Engineering and Biotechnology (CIGB).

'Cuba is working on a 'homegrown' anti-Covid-19 vaccination program and aims to be one of the first in the world to immunize its entire population by the end of 2021, without help from the West,' the article noted. Professor Beate Kampmann, director of the Vaccine Centre at the London School of Hygiene and Tropical Medicine, interviewed by Business Insider, asserted that the Caribbean island has been producing safe drugs for years and 'there is confidence in its ability to deliver candidates against Covid-19.'

For its part, the BBC British news network recalled that Cuba has more than 30 years of experience in biotechnology and immunology.

'In late 1980s, Cuban scientists produced the first vaccine against meningitis B.'

The Pan American Health Organization (PAHO) affirmed that Cuba could become the first Latin American country to produce its own vaccine and once the proposals are finalized, they could also benefit the peoples of Latin America and the Caribbean.